CorMedix Inc
NASDAQ:CRMD
CorMedix Inc
NASDAQ:CRMD
Price:
6.325
USD
0.4%
Market Closed
Market Cap:
$498.3m
Balance Sheet
Balance Sheet Decomposition
CorMedix Inc
CorMedix Inc
Balance Sheet Decomposition is not available for
CorMedix Inc
CorMedix Inc
Balance Sheet
CorMedix Inc
CorMedix Inc
Currency: USD
| Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
3
|
1
|
2
|
8
|
2
|
1
|
2
|
4
|
12
|
8
|
10
|
18
|
16
|
42
|
53
|
43
|
44
|
41
|
|
| Cash Equivalents |
3
|
1
|
2
|
8
|
2
|
1
|
2
|
4
|
12
|
8
|
10
|
18
|
16
|
42
|
53
|
43
|
44
|
41
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
24
|
12
|
2
|
0
|
12
|
4
|
12
|
16
|
32
|
11
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
52
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
52
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
2
|
8
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
4
|
|
| Total Current Assets |
3
|
1
|
2
|
9
|
3
|
1
|
3
|
5
|
37
|
22
|
13
|
19
|
29
|
48
|
66
|
60
|
79
|
115
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
2
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
2
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Other Long-Term Assets |
2
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
4
N/A
|
2
-61%
|
2
+38%
|
9
+297%
|
3
-71%
|
1
-55%
|
3
+158%
|
5
+72%
|
37
+627%
|
22
-41%
|
13
-39%
|
19
+40%
|
29
+57%
|
49
+67%
|
69
+40%
|
62
-10%
|
82
+32%
|
119
+45%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
3
|
1
|
1
|
2
|
2
|
4
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
2
|
4
|
5
|
5
|
3
|
3
|
4
|
7
|
32
|
|
| Short-Term Debt |
7
|
13
|
16
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
9
|
14
|
17
|
2
|
1
|
1
|
2
|
1
|
3
|
4
|
6
|
8
|
6
|
4
|
5
|
6
|
11
|
34
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
|
| Total Liabilities |
9
N/A
|
14
+60%
|
17
+24%
|
2
-91%
|
1
-17%
|
1
+13%
|
7
+369%
|
1
-79%
|
3
+112%
|
4
+32%
|
6
+53%
|
14
+122%
|
6
-58%
|
5
-13%
|
6
+21%
|
7
+13%
|
12
+71%
|
34
+187%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
8
|
17
|
25
|
36
|
43
|
46
|
56
|
76
|
94
|
119
|
152
|
179
|
195
|
217
|
246
|
275
|
322
|
340
|
|
| Additional Paid In Capital |
4
|
5
|
11
|
43
|
44
|
46
|
52
|
80
|
128
|
137
|
159
|
184
|
219
|
262
|
308
|
330
|
392
|
424
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
4
N/A
|
12
-173%
|
15
-22%
|
7
N/A
|
1
-83%
|
0
N/A
|
4
-1 082%
|
4
N/A
|
34
+837%
|
18
-48%
|
7
-60%
|
5
-31%
|
24
+380%
|
44
+87%
|
63
+42%
|
55
-12%
|
70
+27%
|
85
+21%
|
|
| Total Liabilities & Equity |
4
N/A
|
2
-61%
|
2
+38%
|
9
+297%
|
3
-71%
|
1
-55%
|
3
+158%
|
5
+72%
|
37
+627%
|
22
-41%
|
13
-39%
|
19
+40%
|
29
+57%
|
49
+67%
|
69
+40%
|
62
-10%
|
82
+32%
|
119
+45%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
2
|
2
|
2
|
2
|
2
|
2
|
3
|
4
|
7
|
8
|
14
|
22
|
26
|
34
|
38
|
43
|
55
|
64
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
